Titre
Gout: why is this curable disease so seldom cured?
Type
synthèse (review)
Institution
UNIL/CHUV/Unisanté + institutions partenaires
Périodique
Auteur(s)
Doherty, M.
Auteure/Auteur
Jansen, T.L.
Auteure/Auteur
Nuki, G.
Auteure/Auteur
Pascual, E.
Auteure/Auteur
Perez-Ruiz, F.
Auteure/Auteur
Punzi, L.
Auteure/Auteur
So, A.K.
Auteure/Auteur
Bardin, T.
Auteure/Auteur
Liens vers les personnes
Liens vers les unités
ISSN
1468-2060
Statut éditorial
Publié
Date de publication
2012
Volume
71
Numéro
11
Première page
1765
Dernière page/numéro d’article
1770
Langue
anglais
Notes
Publication types: Journal Article ; Research Support, Non-U.S. Gov't
Publication Status: ppublish
Publication Status: ppublish
Résumé
Gout is the most common inflammatory arthritis and one in which pathogenesis and risk factors are best understood. One of the treatment objectives in current guidelines is 'cure'. However, audits show that only a minority of patients with gout receive adequate advice and treatment. Suboptimal care and outcomes reflect inappropriately negative perceptions of the disease, both in patients and providers. Historically, gout has been portrayed as a benign and even comical condition that is self-inflicted through overeating and alcohol excess. Doctors often focus on managing acute attacks rather than viewing gout as a chronic progressive crystal deposition disease. Urate-lowering treatment is underprescribed and often underdosed. Appropriate education of patients and doctors, catalysed by recent introduction of new urate-lowering treatments after many years with no drug development in the field, may help to overcome these barriers and improve management of this easily diagnosed and curable form of potentially severe arthritis.
PID Serval
serval:BIB_A0EA2A8FA659
PMID
Date de création
2012-11-15T17:21:35.210Z
Date de création dans IRIS
2025-05-21T02:44:05Z